PMID- 21565615 OWN - NLM STAT- MEDLINE DCOM- 20110722 LR - 20220310 IS - 1097-4172 (Electronic) IS - 0092-8674 (Print) IS - 0092-8674 (Linking) VI - 145 IP - 4 DP - 2011 May 13 TI - An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. PG - 584-95 LID - 10.1016/j.cell.2011.03.050 [doi] AB - Microglia and astrocytes play essential roles in the maintenance of homeostasis within the central nervous system, but mechanisms that control the magnitude and duration of responses to infection and injury remain poorly understood. Here, we provide evidence that 5-androsten-3beta,17beta-diol (ADIOL) functions as a selective modulator of estrogen receptor (ER)beta to suppress inflammatory responses of microglia and astrocytes. ADIOL and a subset of synthetic ERbeta-specific ligands, but not 17beta-estradiol, mediate recruitment of CtBP corepressor complexes to AP-1-dependent promoters, thereby repressing genes that amplify inflammatory responses and activate Th17 T cells. Reduction of ADIOL or ERbeta expression results in exaggerated inflammatory responses to TLR4 agonists. Conversely, the administration of ADIOL or synthetic ERbeta-specific ligands that promote CtBP recruitment prevents experimental autoimmune encephalomyelitis in an ERbeta-dependent manner. These findings provide evidence for an ADIOL/ERbeta/CtBP-transrepression pathway that regulates inflammatory responses in microglia and can be targeted by selective ERbeta modulators. CI - Copyright (c) 2011 Elsevier Inc. All rights reserved. FAU - Saijo, Kaoru AU - Saijo K AD - Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA. FAU - Collier, Jana G AU - Collier JG FAU - Li, Andrew C AU - Li AC FAU - Katzenellenbogen, John A AU - Katzenellenbogen JA FAU - Glass, Christopher K AU - Glass CK LA - eng GR - DK015556/DK/NIDDK NIH HHS/United States GR - R37 DK015556/DK/NIDDK NIH HHS/United States GR - R01 CA052599-20/CA/NCI NIH HHS/United States GR - R37 DK015556-39/DK/NIDDK NIH HHS/United States GR - R01 DK015556/DK/NIDDK NIH HHS/United States GR - R01 HL087391/HL/NHLBI NIH HHS/United States GR - R01 CA052599-18/CA/NCI NIH HHS/United States GR - HL087391/HL/NHLBI NIH HHS/United States GR - R01 CA052599-19/CA/NCI NIH HHS/United States GR - R01 CA052599/CA/NCI NIH HHS/United States GR - R01 DK091183/DK/NIDDK NIH HHS/United States GR - R01 HL087391-05/HL/NHLBI NIH HHS/United States GR - CA52599/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Cell JT - Cell JID - 0413066 RN - 0 (DNA-Binding Proteins) RN - 0 (Estrogen Receptor beta) RN - 0 (Proto-Oncogene Proteins c-fos) RN - 95PS51EMXY (Androstenediol) RN - EC 1.1.- (17-Hydroxysteroid Dehydrogenases) RN - EC 1.1.- (Alcohol Oxidoreductases) RN - EC 1.1.1.- (C-terminal binding protein) SB - IM CIN - Cell. 2011 May 13;145(4):495-7. PMID: 21565607 CIN - Nat Rev Neurol. 2011 Jul;7(7):355. PMID: 21691333 CIN - Nat Rev Drug Discov. 2011 Jul;10(7):492. PMID: 21720401 MH - 17-Hydroxysteroid Dehydrogenases/metabolism MH - Alcohol Oxidoreductases/metabolism MH - Androstenediol/metabolism MH - Animals MH - Astrocytes/metabolism MH - Cells, Cultured MH - DNA-Binding Proteins/metabolism MH - Encephalomyelitis, Autoimmune, Experimental/*metabolism/prevention & control MH - Estrogen Receptor beta/*metabolism MH - Humans MH - Inflammation/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - Microglia/*metabolism MH - Neurodegenerative Diseases/metabolism MH - Proto-Oncogene Proteins c-fos/metabolism MH - *Signal Transduction PMC - PMC3433492 MID - NIHMS290587 COIS- Conflicts of interest None EDAT- 2011/05/14 06:00 MHDA- 2011/07/23 06:00 PMCR- 2012/09/04 CRDT- 2011/05/14 06:00 PHST- 2010/09/17 00:00 [received] PHST- 2011/02/22 00:00 [revised] PHST- 2011/03/28 00:00 [accepted] PHST- 2011/05/14 06:00 [entrez] PHST- 2011/05/14 06:00 [pubmed] PHST- 2011/07/23 06:00 [medline] PHST- 2012/09/04 00:00 [pmc-release] AID - S0092-8674(11)00427-2 [pii] AID - 10.1016/j.cell.2011.03.050 [doi] PST - ppublish SO - Cell. 2011 May 13;145(4):584-95. doi: 10.1016/j.cell.2011.03.050.